Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00286429 · ClinicalTrials.gov registry record · Phase 3

Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.

A Phase 3 study of Diabetes Mellitus, sponsored by Takeda.

Completed
Registry status
Phase 3
Development phase
390
Enrollment target
20
Study locations

NCT00286429 is a Phase 3 study of Diabetes Mellitus that has completed, run by Takeda. The registered enrollment target is 390 participants, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (79% lower). The trial reports 20 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00286429, a Phase 3 study of Diabetes Mellitus, has completed, sponsored by Takeda.

COMPLETED
Registry status
Phase 3
Development phase
390 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to determine the efficacy and safety of alogliptin, once daily (QD), taken in combination with insulin for the treatment of Type 2 Diabetes.

Conditions Studied

Diabetes Mellitus

Interventions

  • DRUG Insulin
  • DRUG Alogliptin and insulin

Study Locations (20)

California

  • - Anaheim
  • - Artesia
  • - Fresno
  • - Mission Viejo
  • - Northridge
  • - Orange
  • - San Diego
  • - Tustin
  • - Walnut Creek

Florida

  • - Cocoa Beach
  • - Longwood
  • - New Port Richey
  • - Ocala
  • - Saint Cloud
  • - Tampa

Arizona

  • - Phoenix

Colorado

  • - Denver

Georgia

  • - Lawrenceville

Hawaii

  • - Honolulu

Indiana

  • - Avon

Trial Details

FieldValue
Enrollment Target 390 participants
Start Date 2006-02
Est. Completion 2007-05
Phase Phase 3

Sponsor

Takeda

408 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00286429

The ClinicalTrials.gov registry entry for NCT00286429 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 390 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (79% lower). The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Insulin is the first listed.

NCT00286429 reports 20 study locations spanning 7 distinct geographic areas - top geographies include California, Florida, Arizona.

Frequently Asked Questions

What is clinical trial NCT00286429 about?

NCT00286429 is a clinical study titled "Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.". The purpose of this study is to determine the efficacy and safety of alogliptin, once daily (QD), taken in combination with insulin for the treatment of Type 2 Diabetes.

What is the current status of trial NCT00286429?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 390 participants. The study started on 2006-02. Estimated completion is 2007-05.

What conditions does trial NCT00286429 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT00286429?

The interventions under investigation include: Insulin (DRUG), Alogliptin and insulin (DRUG).

Who is sponsoring clinical trial NCT00286429?

This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00286429 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.